Bisphosphonate therapy for juvenile dermatomyositis-associated calcinosis and metaphyseal zebra lines
- PMID: 36343985
- PMCID: PMC9644302
- DOI: 10.1136/bcr-2022-252814
Bisphosphonate therapy for juvenile dermatomyositis-associated calcinosis and metaphyseal zebra lines
Keywords: Connective tissue disease; Drugs: musculoskeletal and joint diseases.
Conflict of interest statement
Competing interests: None declared.
Figures





References
-
- Twilt M, Feldman BM. An update on the diagnosis and management of juvenile dermatomyositis. Int J Clin Rheumtol 2012;7:325–33. 10.2217/ijr.12.23 - DOI
-
- Orandi AB, Baszis KW, Dharnidharka VR, et al. . Assessment, classification and treatment of calcinosis as a complication of juvenile dermatomyositis: a survey of pediatric rheumatologists by the childhood arthritis and rheumatology research alliance (CARRA). Pediatr Rheumatol 2017;15:71. 10.1186/s12969-017-0199-4 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources